Sirna Therapeutics said last week that it has named Martin Schmieg as senior vice president and CFO.
Schmieg will direct and oversee Sirna’s financial management, accounting activities, and investor and public relations, and will begin at the company on Sept. 20.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.